Categories: Business News

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Aug 2 (Reuters) – UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: August 3, 2026 01:27:13 IST

Aug 2 (Reuters) – UK drugmaker AstraZeneca has been exploring a deal to combine with U.S. rival Bristol Myers Squibb, the Financial Times reported on Sunday, citing people familiar with the matter.

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: August 3, 2026 01:27:13 IST

Recent Posts

UPDATE 8-Serie A Summaries

Nov 7 (OPTA) - Summaries for the Serie A on Saturday (start times are CET)…

November 8, 2026

Maresca bemoans City's lack of intensity after third straight Premier League defeat

VIDEO SHOWS: PRESS CONFERENCE WITH MANCHESTER CITY MANAGER, ENZO MARESCA RESENDING WITH COMPLETE SCRIPT SHOWS:…

November 8, 2026

UPDATE 13-NCAAB Results

Nov 7 (Stats Perform) - Results from the NCAAB games on Saturday (home team in…

November 8, 2026